While other studies have reported a failure to detect CTNNB1 mutations in a proportion of ACP samples, these results rather reflect methodological limitations such as an insensitive sequencing approach and/or a low proportion of the analyzed tumor tissue in the samples that were analyzed [42,43]. Here, CTNNB1 is linked to neoplasm.